Solid Organ Transplant Symposium – Pushing the Boundaries & Equalizing Access

885 Tiverton Ave, Los Angeles, CA 90024

View map

Registration will be closed at 12:00 PM on Thursday, June 29, 2023.
After the online registration is closed, please visit on-site to register for in-person participation. For virtual attendance, please email ccpd@mednet.ucla.edu or call 310-794-2620 to register. 

The UCLA Solid Organ Transplant Symposium is an in-person and virtual education conference coordinated through UCLA Health Department of Transplant Services; the UCLA Center for Continuing Professional Development and the UCLA Transplant Multi-Disciplinary teams. The goal of this program is to provide a forum for UCLA Transplant multidisciplinary team experts to discuss challenges faced by solid organ transplant teams during pre- and post-transplant patient management and how we are addressing the challenges of equal access in the face of the ever growing organ shortage and our desire to provide transplant for all in need.

4th Annual UCLA Solid Organ Transplant Symposium Brochure (PDF)

Target Audience

The target audience for this symposium is health care professionals who provide care for patients pre- and post-transplant including: Heart, Lung, Liver, Kidney, Pancreas and Intestinal/Multivisceral transplantation. The symposium content is designed for local community physicians, transplant nurses, transplant nurse coordinators, administrators, nurse practitioners, pharmacists, social workers, dietitians and all members of the transplant team to guide and improve their clinical practice and patient management during all phases of transplantation.

REGISTRATION INFORMATION

Registration will be closed at 12:00 PM on Thursday, June 29, 2023.
After the online registration is closed, please visit on-site to register for in-person participation. For virtual attendance, please email ccpd@mednet.ucla.edu or call 310-794-2620 to register. 

Attendees will be provided breakfast, lunch, and refreshments at the conference. All attendees are welcome to attend our reception held following the conference.

Course Fee

$75 Live In-Person Registration
$50 Virtual Registration
$30 Student Fee

Refunds

Cancellations must be received by email to ccpd@mednet.ucla.edu by June 9, 2023. No refunds will be granted after that date. If, for any reason, the course must be cancelled, discontinued, or rescheduled, a full refund will be provided.

Questions

If you have questions about enrollment, please email ccpd@mednet.ucla.edu or call (310) 794-2620.

PARKING AND DIRECTION

From the 405 freeway, exit Wilshire Blvd., East toward Westwood. Turn left on Westwood Blvd. and turn right on Le Conte Ave. Then, turn left on Tiverton Ave. Once you turn in on Tiverton, go straight into the Geffen Hall parking structure labeled “Visitor Parking 18 & 27”. Proceed left to “Visitor Parking 18”. Please park in the “Visitor Parking 18” Lot. Please use the pay-by-plate station to purchase your parking permit. Participants are responsible for their own parking charges at a rate of $15 per vehicle. The Geffen Hall Auditorium is located at the intersection of Le Conte Ave. and Tiverton Ave.

EXHIBITOR INFORMATION

Please email ccpd@mednet.ucla.edu.

OBJECTIVES

Following completion of the course, attendees should be able to:

  • Identify areas of inequity in solid organ transplantation
  • Provide strategies through policy, education and research to address equity issues and access to quality health care for all transplant patients
  • Identify 2 barriers to solid organ transplantation
  • Identify the significance and clinical application of cell-free DNA testing (cfDNA) in kidney transplant recipients
  • Discuss patient journeys with history of cholangiocarcinoma (including state of the art treatment, surgical options, and UNOS MELD exception rules) and identify barriers to treatment and areas in need of future research
  • Define alcohol hepatitis as an indication for liver transplantation and identify the evaluation and management: patient outcomes as well as resources available
  • Describe the impact the Opioid Epidemic has on transplant patients
  • Identify strategies for weight management to optimize post-transplant outcomes
  • Describe the importance of the caregiver role in post-transplant success

ACCREDITATION

The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The David Geffen School of Medicine at UCLA, designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved for the AMA PRA Category 1 Credits™ as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

The American Board for Transplant Certification (ABTC) has approved this educational offering for up to 7.25 Category One Continuing Education Points for Transplant Certification (CEPTCs).

DISCLOSURES

The FDA has issued a concept paper that classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is “truly independent” and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manage all identified potential conflicts of interest prior to the program. UCLA fully endorses the letter and spirit of these concepts.